Clinical trial
A Randomized, Double-blind, Placebo-controlled, Two-Part Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
NCT05163808 is registered in ClinicalTrials.gov with Tetra Discovery Partners as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Double-blind, Placebo-controlled, Two-Part Study of BPN14770 in Male Adolescents (Aged 9 to < 18 Years) With Fragile X Syndrome
- Lead sponsor
- Tetra Discovery Partners
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 29, 2022
- Completion date
- September 2, 2025
- Enrollment
- 163 (actual)
- Sites
- 17
Conditions
As the registry lists them; a condition with its own page is linked.